NextGen Healthcare Completes Acquisition of Medfusion
Summary
IRVINE, Calif.--(BUSINESS WIRE)--NextGen Healthcare, Inc. (NASDAQ: NXGN), a leading provider of ambulatory-focused technology solutions, today announced it has completed the acquisition of Medfusion, Inc. (“Medfusion”) a patient experience platform leader. “Patient experience drives patient engagement, which leads to better health outcomes,” said Rusty Frantz, President and CEO of NextGen Healthcare. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. Forward-looking statements can be identified by the use of words such as "believe," "expect," "expectations," "plans," "strategy," "prospects," "estimate," "project," "target," "anticipate," "will," “will continue,” “potential,” "should," "see," "guidance," "outlook," "confident," "on track" and other words of similar meaning. Such risks, uncertainties and other factors include, without limitation: (1) successful integration of Medfusion’s personnel, systems and business; (2) the scope, nature or impact of the acquisition, including among other things the integration of or with other businesses and realization of synergies and opportunities for growth and innovation and incurrence of related costs and expenses; (3) the effect of economic conditions in the industries and markets in which the Company operates in the U.S. and globally and any changes therein; (4) company and customer-directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (5) new business and investment opportunities; (6) the ability to realize the intended benefits of organizational changes; (7) the outcome of legal proceedings, investigations and other contingencies; (8) negative effects of the announcement or pendency of the acquisition on the market price of the Company’s common stock and/or on its financial performance; (9) the possibility that the anticipated benefits from the acquisition cannot be realized in full or at all or may take longer to realize than expected, including risks associated with third party contracts containing consent and/or other provisions that may be triggered by the transaction; and (10) risks associated with transaction-related litigation.